These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14975550)

  • 1. Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey.
    Bongard V; Grenier O; Ferrières J; Danchin N; Cantet C; Amelineau E; Cambou JP
    Int J Cardiol; 2004 Feb; 93(2-3):217-23. PubMed ID: 14975550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No gender difference in the clinical management and outcome of unstable angina.
    Ben-Ami T; Gilutz H; Porath A; Sosna G; Liel-Cohen N
    Isr Med Assoc J; 2005 Apr; 7(4):228-32. PubMed ID: 15847201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in management after acute myocardial infarction: not 'sexism' but a reflection of age at presentation.
    Williams RI; Fraser AG; West RR
    J Public Health (Oxf); 2004 Sep; 26(3):259-63. PubMed ID: 15454593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care.
    McGovern MP; Boroujerdi MA; Taylor MW; Williams DJ; Hannaford PC; Lefevre KE; Simpson CR
    Fam Pract; 2008 Feb; 25(1):33-9. PubMed ID: 18222938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific profile and referral bias of rehabilitated patients after an acute coronary syndrome.
    Cottin Y; Cambou JP; Casillas JM; Ferrières J; Cantet C; Danchin N
    J Cardiopulm Rehabil; 2004; 24(1):38-44. PubMed ID: 14758102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good judgement or sex bias in the referral of patients for the diagnosis of coronary artery disease? An exploratory study.
    Jaglal SB; Slaughter PM; Baigrie RS; Morgan CD; Naylor CD
    CMAJ; 1995 Mar; 152(6):873-80. PubMed ID: 7697580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gender on treatment, resource utilization, and outcomes in congestive heart failure in Quebec, Canada.
    Sheppard R; Behlouli H; Richard H; Pilote L
    Am J Cardiol; 2005 Apr; 95(8):955-9. PubMed ID: 15820161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW; Madhavan SS; Amonkar MM
    Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of unstable angina and non-ST-elevation myocardial infarction: do cardiologists do it better? A comparison of secondary and tertiary centre management in New Zealand.
    Conaglen P; Sebastian C; Jayaraman C; Abraham A; Makkada V; Devlin G
    N Z Med J; 2004 May; 117(1194):U890. PubMed ID: 15156208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
    Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
    Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database.
    Tuppin P; Neumann A; Danchin N; Weill A; Ricordeau P; de Peretti C; Allemand H
    Arch Cardiovasc Dis; 2009 Apr; 102(4):279-92. PubMed ID: 19427605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.
    Vitagliano G; Curtis JP; Concato J; Feinstein AR; Radford MJ; Krumholz HM
    J Am Geriatr Soc; 2004 Apr; 52(4):495-501. PubMed ID: 15066062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
    Page RL; Ruscin JM
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender bias in cardiovascular testing persists after adjustment for presenting characteristics and cardiac risk.
    Chang AM; Mumma B; Sease KL; Robey JL; Shofer FS; Hollander JE
    Acad Emerg Med; 2007 Jul; 14(7):599-605. PubMed ID: 17538080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.